Poor Sleep Quality Affects 58% of Parkinson's Disease Patients Worldwide
Meta-analysis of 63 studies reveals sleep problems are widespread in Parkinson's disease, with late-onset cases showing worse outcomes.
Summary
A comprehensive meta-analysis of 63 studies involving 9,382 Parkinson's disease patients found that 58% experience poor sleep quality. The research identified key factors contributing to sleep problems, including late disease onset, geographic location, and diagnostic criteria used. This represents the first systematic review quantifying sleep quality issues across the global Parkinson's population.
Detailed Summary
Sleep problems are among the most debilitating non-motor symptoms of Parkinson's disease (PD), yet their true prevalence has remained unclear due to varying study methodologies and populations. This groundbreaking meta-analysis provides the first comprehensive global assessment of poor sleep quality in PD patients.
Researchers systematically analyzed 63 studies encompassing 9,382 PD patients from multiple databases through November 2023. Using standardized sleep assessment tools like the Pittsburgh Sleep Quality Index (PSQI), they found an overall poor sleep quality prevalence of 58.07% (95% CI: 54.26-61.88%). This represents a substantial burden affecting more than half of all PD patients worldwide.
Several factors significantly influenced sleep quality outcomes. Studies from Europe and Central Asia reported higher rates of poor sleep, as did research from upper-middle-income countries. Patients with late-onset PD showed particularly poor sleep quality in meta-regression analysis. Interestingly, studies using Movement Disorder Society diagnostic criteria and lower diagnostic cutoff values also identified more sleep problems.
The research revealed concerning gaps in global representation, with most studies conducted in high-income countries, potentially limiting applicability to diverse populations. The authors emphasize that poor sleep quality in PD patients correlates with more severe depression, anxiety, cognitive decline, and overall disease progression, making sleep management crucial for comprehensive care.
These findings underscore the critical need for routine sleep quality monitoring and targeted sleep hygiene interventions in PD management protocols worldwide.
Key Findings
- 58.07% of Parkinson's disease patients experience poor sleep quality globally (95% CI: 54.26-61.88%)
- Meta-analysis included 63 studies with 9,382 PD patients across multiple countries and diagnostic criteria
- Late-onset Parkinson's disease was significantly associated with worse sleep quality in meta-regression analysis
- Studies from Europe & Central Asia and upper-middle-income countries reported higher rates of poor sleep quality
- Movement Disorder Society PD diagnostic criteria identified more sleep problems compared to other criteria
- Lower diagnostic cutoff values on sleep assessment tools detected higher prevalence rates
- High heterogeneity between studies (I² > 75%) indicated substantial variation in methodology and populations
Methodology
This systematic review followed PRISMA and MOOSE guidelines, searching six databases from inception through November 2023. Researchers included cross-sectional and cohort studies using validated sleep assessment tools like PSQI and PDSS. Study quality was assessed using an 8-item standardized tool, with random-effects models used for pooled prevalence calculations and subgroup analyses exploring sources of heterogeneity.
Study Limitations
The study showed high heterogeneity between included studies, indicating substantial methodological differences. Most research came from high-income countries, limiting global applicability. The authors excluded studies specifically focused on PD patients with primary sleep disorders, which may have underestimated the true prevalence. Cross-sectional design prevents establishing causality between identified factors and sleep quality.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
